---
title: "Why the Alnylam sell-off looks overdone -- and what investors are missing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296021784.md"
description: "Yes, Alnylam has had some bad news. But the bad news isn't as horrible as many think."
datetime: "2026-08-16T11:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296021784.md)
  - [en](https://longbridge.com/en/news/296021784.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296021784.md)
generator: "portal-rs"
---

# Why the Alnylam sell-off looks overdone -- and what investors are missing

Yes, Alnylam has had some bad news. But the bad news isn't as horrible as many think.

### Related Stocks

- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)

## Related News & Research

- [16:58 ETInvestor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firm](https://longbridge.com/en/news/296031373.md)
- [16:00 ET(NASDAQ: ALNY) Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. Investors to Contact the Firm](https://longbridge.com/en/news/296687484.md)
- [Alnylam Pharmaceuticals misses Q2 street views](https://longbridge.com/en/news/294375290.md)
- [How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA](https://longbridge.com/en/news/296250302.md)
- [This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday](https://longbridge.com/en/news/296352846.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**